Objective: Describe the contemporary features of coagulase-negative staphylococcal (CoNS) prosthetic valve endocarditis (PVE).
Design: Observational study of prospectively collected data from a multi-national cohort of patients with infective endocarditis. Patients with CoNS PVE were compared to patients with S. aureus and viridans streptococcal (VGS) PVE.
Setting: The International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) is a contemporary cohort of patients with infective endocarditis from 61 centers in 28 countries.
Patients: Adult patients in the ICE-PCS with definite PVE and no history of injection drug use from 6/00–8/05 were included.
Main Outcome Measures: Heart failure, intracardiac abscess, death.
Results: CoNS caused 16% (n=86) of 537 cases of definite non-injection drug use-associated PVE. Nearly one-half (n=33/69, 48%) of patients with CoNS PVE presented between 60 and 365 days of valve implantation. The rate of intracardiac abscess was significantly higher in patients with CoNS PVE (38%) than in patients with either S. aureus (23%, p= 0.03) or VGS (20%, p= 0.05) PVE. The rate of abscess was particularly high in early (50%) and intermediate (52%) CoNS PVE. In-hospital mortality was 24% for CoNS PVE, 36% for S. aureus PVE (p=0.09), and 9.1% for VGS PVE (p=0.08). Methicillin resistance was present in 68% of CoNS strains.
Conclusions: Nearly one-half of CoNS PVE cases occur between 60 and 365 days of prosthetic valve implantation. CoNS PVE is associated with a high rate of methicillin resistance and significant valvular complications.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.